Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter J Nelson

Showing results (21-30 of 178) with videos related to

Pageof 18
Sort By:
Journal of the American Society of Nephrology : JASN|January 5, 2000
Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studiesStephan Segerer, Peter J Nelson, Detlef Schlöndorff
Blood|June 11, 2011
Comparative promoter analysis in vivo: identification of a dendritic cell-specific promoter moduleStephanie L Edelmann, Peter J Nelson, Thomas Brocker
Nephron. Experimental Nephrology|March 12, 2009
Renal dendritic cells: an updatePeter Velázquez, Michael L Dustin, Peter J Nelson
Endocrine-Related Cancer|May 8, 2019
Tetrac as an anti-angiogenic agent in cancerKathrin A Schmohl, Peter J Nelson, Christine Spitzweg
Stem Cells (Dayton, Ohio)|November 8, 2012
Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancyEmily Z Keung, Peter J Nelson, Claudius Conrad
Drug News & Perspectives|September 15, 2006
CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseasesTimothy J Soos, Laurent Meijer, Peter J Nelson
Nephron. Experimental Nephrology|December 3, 2011
Dendritic cells in experimental renal inflammation--Part IMaja Lindenmeyer, Elfriede Noessner, Peter J Nelson, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytesPeter J Nelson, Irwin H Gelman, Paul E Klotman
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2003
Computer modeling of promoter organization as a tool to study transcriptional coregulationThomas Werner, Sabine Fessele, Holge Maier, et al.
Expert Opinion on Therapeutic Targets|June 1, 2011
Wnt-signaling pathways in progressive renal fibrosisPeter J Nelson, Christine von Toerne, Hermann-Josef Gröne
Pageof 18

Showing results (21-30 of 178) with videos related to

Sort By:
Pageof 18
Journal of the American Society of Nephrology : JASN|January 5, 2000
Chemokines, chemokine receptors, and renal disease: from basic science to pathophysiologic and therapeutic studiesStephan Segerer, Peter J Nelson, Detlef Schlöndorff
Blood|June 11, 2011
Comparative promoter analysis in vivo: identification of a dendritic cell-specific promoter moduleStephanie L Edelmann, Peter J Nelson, Thomas Brocker
Nephron. Experimental Nephrology|March 12, 2009
Renal dendritic cells: an updatePeter Velázquez, Michael L Dustin, Peter J Nelson
Endocrine-Related Cancer|May 8, 2019
Tetrac as an anti-angiogenic agent in cancerKathrin A Schmohl, Peter J Nelson, Christine Spitzweg
Stem Cells (Dayton, Ohio)|November 8, 2012
Concise review: genetically engineered stem cell therapy targeting angiogenesis and tumor stroma in gastrointestinal malignancyEmily Z Keung, Peter J Nelson, Claudius Conrad
Drug News & Perspectives|September 15, 2006
CDK/GSK-3 inhibitors as a new approach for the treatment of proliferative renal diseasesTimothy J Soos, Laurent Meijer, Peter J Nelson
Nephron. Experimental Nephrology|December 3, 2011
Dendritic cells in experimental renal inflammation--Part IMaja Lindenmeyer, Elfriede Noessner, Peter J Nelson, et al.
Journal of the American Society of Nephrology : JASN|December 1, 2001
Suppression of HIV-1 expression by inhibitors of cyclin-dependent kinases promotes differentiation of infected podocytesPeter J Nelson, Irwin H Gelman, Paul E Klotman
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|July 2, 2003
Computer modeling of promoter organization as a tool to study transcriptional coregulationThomas Werner, Sabine Fessele, Holge Maier, et al.
Expert Opinion on Therapeutic Targets|June 1, 2011
Wnt-signaling pathways in progressive renal fibrosisPeter J Nelson, Christine von Toerne, Hermann-Josef Gröne
Pageof 18